척추 바이오로직스 시장 : 제품 유형별, 용도별, 수술 유형별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

Spine Biologics Market size was valued at US$ 3,205.4 Million in 2025, expanding at a CAGR of 4.9% from 2026 to 2033.

The growth of regenerative orthopedics has been a significant boon to the spine biologics market. This market provides biological and bioactive materials for the regeneration of bone tissue, used in spinal fusion, and for the restoration, reconstruction, and repair of the spine. The market consists of demineralized bone matrix, bone graft, graft substitute, spinal allografts, synthetic grafts, bone morphogenetic proteins, cellular matrices, and other products useful for various spine surgeries. One of the significant factors contributing to the development of this market is the growing trend of minimally invasive spine surgery. Hence, the use of biologics for faster and stronger vertebral fusion after surgery is gaining popularity in the global market due to less invasive procedures.

Spine Biologics Market- Market Dynamics

Growing Adoption of Minimally Invasive Spine Surgery Accelerates Demand for Advanced Spine Biologics

Minimally invasive spine surgeries (MISS) are driving demand for innovative spine biologics to repair minimal amounts of tissue at the time of a small incision. Synthetic bone graft substitutes, peptide enhanced grafts, and cellular matrices, in combination with navigation assisted and robotic spine surgery, offer potential to improve fusion rates. Medivis gained FDA 510 (k) clearance for their augmented reality-based Spine Navigation platform in the U.S and launched it for open and MISS procedures in 2025. In parallel, Cerapedics received FDA approval for its PearlMatrix P-15 peptide enhanced bone graft with positive Level-1 clinical trial data reporting over twice the rate of patients achieving fusion at 6 months versus local autograft control, fueling confidence in next generation spine biologics for lumbar fusion.

Spine Biologics Market- Segmentation Analysis:

The Global Spine Biologics Market is segmented on the basis of Product Type, Application, Surgery Type, End User, and Region.

Under product, bone graft substitutes dominate the market due to the need to avoid donor site morbidity and provide multiple handling options and predictable osteoconductive for spinal fusion. Demineralized bone matrix and structural allografts represent the most preferred options for complex reconstructions with combined biological and biomechanical restitution needs. For instance, in 2025, Cerapedics received FDA approval for the USA for its PearlMatrix P-15 peptide-enhanced bone graft for lumbar fusion, while Ventris Medical's Backpack Bone Graft received FDA 510 (k) clearance to enter the intervertebral disc space. In general, the industry is witnessing a biological grafts' boom.

Under application, spinal fusion is the key area in terms of biologics that will benefit from the minimally invasive fixation systems development enabled by the rising number of complex deformity and degenerative disc disease with segment instability procedures. In addition, spinal fusion is the primary application for biologics used in conjunction with minimally invasive fixation systems for the treatment of complex deformity, degenerative disc disease, and segment instability. On the other hand, hospitals utilize biologics in combination with minimally invasive fixation systems to standardize the fusion rates in complex procedures. Specifically, Cerapedics announced in 2025 that its ASPIRE pivotal study found PearlMatrix to achieve more than twice the fusion rate compared to local autograft at six months for patients with high-risk deformity and instability. Overall, the study included 60 percent of high-risk patients, therefore, reflecting the confidence of surgeons in biologics for complex reconstructions and revisions.

Spine Biologics Market- Geographical Insights

North America is the largest market for spine biologics, attributable to the presence of a large number of medical device companies, research institutes, spine surgery hospitals, and FDA approvals for prominent navigational spine technologies for 510 (k) and biologics-based minimally invasive spine surgeries in 2025. For example, Kuros Biosciences became the first company in the U.S. to treat patients in clinical settings using its newly approved orthopedic biologics graft delivery, the MagnetOs MIS Delivery System by the FDA. Further, a number of navigational and fusion products were approved in the region for commercialization, creating an exigency for minimally invasive spine surgeries.

The Europe spine biologics market is likely to witness rapid growth due to the increasing need for advanced spinal fusion procedures and the continuous adoption of new products. The market growth is anticipated on the back of a favorable regulatory environment, research hubs, and medical infrastructure well-equipped with spine surgery hospitals in the region. For example, as reported in 2025, SpineGuard announced the expansion of sales of its Threaded PediGuard system for spine surgeries after achieving the CE-MDR certification for anterior spine procedures. Similarly, a number of companies engaged in spinal biologics manufacturing are taking advantage of the regulatory environment in the EU to develop a variety of biomaterials for different minimally invasive spine procedures. Additionally, research collaborations, tissue-banking initiatives, and quality management systems in the region promote the uptake of multiple treatment options while complying with the MDR regulations.

Spine Biologics Market- Competitive Landscape:

Competition in the spine biologics market consists of the introduction of new clinically relevant biomaterials and minimally invasive spine delivery technologies, as well as commercial partnerships. In January 2025, Kuros Biosciences and Medtronic announced an extended U.S sales agreement for Kuros' MagnetOs(TM) Bone Graft technologies for an additional five years. The collaboration aims to expand access to care within the company's U.S spine franchise by enabling surgeons to treat specific indications in patients. In August 2025, Kuros announced that it performed the first U.S clinical procedures using its FDA-cleared MagnetOs(TM) MIS Delivery System. It is a prefilled, sterile, and human tissue-free graft delivery device intended to simplify the procedure of minimally invasive spine surgery while facilitating the introduction of bone grafts into the surgical site. Additionally, companies are developing synthetic bone graft substitutes, regenerative biologics, automated biologics manufacturing quality control systems, and differentiation strategies to drive competition in the market.

Recent Developments:

In May 2025, Orthofix Medical received U.S. FDA 510(k) clearance for the TrueLok Elevate Transverse Bone Transport System, expanding its limb reconstruction and bone regeneration portfolio while strengthening the company's biologics-supported orthopedic solutions.

In August 2025, Kuros Biosciences commercially launched the MagnetOs MIS Delivery System following FDA clearance, enabling minimally invasive delivery of its synthetic bone graft technology for spinal fusion procedures across the U.S. market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SPINE BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Medtronic plc
• Stryker Corporation
• DePuy Synthes Companies
• Zimmer Biomet Holdings, Inc.
• Globus Medical, Inc.
• Orthofix Medical Inc.
• Bioventus Inc.
• Cerapedics Inc.
• Alphatec Holdings, Inc.
• Xtant Medical Holdings, Inc.
• Kuros Biosciences AG
• Integra LifeSciences Holdings Corporation
• Arthrex, Inc.
• Others

GLOBALSPINE BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

• Bone Graft Substitutes
• Bone Morphogenetic Proteins
• Synthetic Bone Grafts
• Spinal Allografts
• Machined Bone Allografts
• Demineralized Bone Matrix
• Cell-Based Matrices
• Others

GLOBAL SPINE BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Scoliosis Correction
• Fracture Repair
• Spinal Fusion
• Non-Fusion Procedures
• Others

GLOBAL SPINE BIOLOGICS MARKET, BY SURGERY TYPE- MARKET ANALYSIS, 2020 - 2033

• Anterior Cervical Discectomy and Fusion (ACDF)
• Lateral Lumbar Interbody Fusion (LLIF)
• Posterior Lumbar Interbody Fusion (PLIF)
• Anterior Lumbar Interbody Fusion (ALIF)
• Transforaminal Lumbar Interbody Fusion (TLIF)
• Posterolateral Fusion (PLF)
• Others

GLOBAL SPINE BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

• Specialty Orthopedic & Spine Clinics
• Hospitals & ASCs
• Others

GLOBAL SPINE BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Spine Biologics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Spine Biologics Market Snippet by Product Type
  • 2.1.2. Spine Biologics Market Snippet by Application
  • 2.1.3. Spine Biologics Market Snippet by Surgery Type
  • 2.1.4. Spine Biologics Market Snippet by End User
  • 2.1.5. Spine Biologics Market Snippet by Country
  • 2.1.6. Spine Biologics Market Snippet by Region
• 2.2. Competitive Insights

3. Spine Biologics Key Market Trends

• 3.1. Spine Biologics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Spine Biologics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Spine Biologics Market Opportunities
• 3.4. Spine Biologics Market Future Trends

4. Spine Biologics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Spine Biologics Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Spine Biologics Market Landscape

• 6.1. Spine Biologics Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Spine Biologics Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
  • 7.1.2. Bone Graft Substitutes
    • 7.1.2.1. Bone Morphogenetic Proteins
    • 7.1.2.2. Synthetic Bone Grafts
  • 7.1.3. Spinal Allografts
    • 7.1.3.1. Machined Bone Allografts
    • 7.1.3.2. Demineralized Bone Matrix
  • 7.1.4. Cell-Based Matrices
  • 7.1.5. Others

8. Spine Biologics Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 8.1.2. Scoliosis Correction
  • 8.1.3. Fracture Repair
  • 8.1.4. Spinal Fusion
  • 8.1.5. Non-Fusion Procedures
  • 8.1.6. Others

9. Spine Biologics Market - By Surgery Type

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Surgery Type, 2025 & 2033 (%)
  • 9.1.2. Anterior Cervical Discectomy and Fusion (ACDF)
  • 9.1.3. Lateral Lumbar Interbody Fusion (LLIF)
  • 9.1.4. Posterior Lumbar Interbody Fusion (PLIF)
  • 9.1.5. Anterior Lumbar Interbody Fusion (ALIF)
  • 9.1.6. Transforaminal Lumbar Interbody Fusion (TLIF)
  • 9.1.7. Posterolateral Fusion (PLF)
  • 9.1.8. Others

10. Spine Biologics Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 10.1.2. Specialty Orthopedic & Spine Clinics
  • 10.1.3. Hospitals & ASCs
  • 10.1.4. Others

11. Spine Biologics Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Spine Biologics Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Spine Biologics Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Spine Biologics Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Spine Biologics Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Spine Biologics Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Surgery Type, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Spine Biologics Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Medtronic plc
  • 12.2.2. Stryker Corporation
  • 12.2.3. DePuy Synthes Companies
  • 12.2.4. Zimmer Biomet Holdings, Inc.
  • 12.2.5. Globus Medical, Inc.
  • 12.2.6. Orthofix Medical Inc.
  • 12.2.7. Bioventus Inc.
  • 12.2.8. Cerapedics Inc.
  • 12.2.9. Alphatec Holdings, Inc.
  • 12.2.10. Xtant Medical Holdings, Inc.
  • 12.2.11. Kuros Biosciences AG
  • 12.2.12. Integra LifeSciences Holdings Corporation
  • 12.2.13. Arthrex, Inc.
  • 12.2.14. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us